Screener
TG Therapeutics TGTX Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from TG Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
FAQ
- What is TG Therapeutics's net margin?
- TG Therapeutics (TGTX) reported net margin of 55.2% in Q2 2026.
- How has TG Therapeutics's net margin changed year-over-year?
- TG Therapeutics's net margin increased by 314.7% year-over-year, from 13.3% to 55.2%.
- What is the long-term trend for TG Therapeutics's net margin?
- Over 4 years (2020 to 2025), TG Therapeutics's net margin has grown at a -85.9% compound annual growth rate (CAGR), from -183,803.3% to 72.6%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about TG Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude